The One Lambda™ LABScreen™ product portfolio continues to improve advances in HLA antibody detection by our continued research to develop more stable HLA class II antigens, reducing potential denatured reactions in HLA antibody tests due to pan DR activity. Learn how the LABScreen ReFlex platform removes pan-DR reactivity, resolves discordant class II reactivity, and reveals true specificity for HLA class II antigens. Also learn about PreSorb, which removes an autoreactive antibody in serum that recognizes an antigenic determinant for all DR alleles as well as Cw1, Cw12, and Cw15 epitopes.
Dave Lowe, PhD, FRC Path
Senior Research and Development Director, Thermo Fisher Scientific
West Hills, CA USA
Oct 20, 2021
Please sign in to access your account. Customers must log in to access some content, recorded webinars, training materials, documents, and software.
Please provide the following to setup your user account. If you do not know your center ID, please leave the center ID field blank.
Passwords do not match